• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Vaccines, Blood & Biologics

  • Print
  • Share
  • E-mail


STN: 125430
Proper Name: Varicella Zoster Immune Globulin
Manufacturer: Cangene Corporation

  • For postexposure prophylaxis in high risk individuals. High risk groups include:
    • immunocompromised children and adults,
    • newborns of mothers with varicella shortly before or after delivery,
    • premature infants,
    • infants less than one year of age,
    • adults without evidence of immunity,
    • pregnant women.